In this Issue:
Silent CSII occlusions reduced with a novel catheter
DPP-4 activity increased in type 1 diabetes
Hypoglycaemia and QT-interval prolongation
Intensifying treatment in basal insulin-treated type 2 diabetes
CSII efficacy and safety in type 1 diabetes
Effect of antihypertensive treatment at different BPs in diabetes
Diabetes as an indication for renin angiotensin system blockers
Metformin’s glucose-lowering effect resides in the gut
Ten-year CV outcomes with pioglitazone in type 2 diabetes
Vitamin C/E supplements do not affect placental indices in type 1 diabetes during pregnancy
Please login below to download this issue (PDF)